Proton pump inhibitors and fracture risk: true effect or residual confounding?
Fracture is a major contributor to human morbidity and mortality, especially in the elderly. It has been discussed in the literature that conditions associated with decreased stomach acidity may lead to a decrease in intestinal calcium absorption and, consequently, to an increased fracture risk. In recent years, several observational studies reported a slightly increased fracture risk in association with the use of proton pump inhibitors (PPIs) and/or histamine H(2) receptor antagonists. It was the objective of this review to critically assess the available evidence linking PPI use to an increased fracture risk. A MEDLINE and EMBASE search from 1960 to June 2010 was performed to identify the relevant articles using predefined search terms. Because (i) there is no proven mechanism, (ii) the reported magnitude of the risk elevation associated with the use of PPIs was only weak, and (iii) the likelihood of residual confounding despite adjustment for known co-morbidities and drug use cannot be ruled out, we conclude that the currently available literature does not support the notion that the use of PPIs is causally related to a materially increased fracture risk in humans.
Bodmer
Michael
M
Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
Meier
Christian
C
Kraenzlin
Marius E
ME
Meier
Christoph R
CR
D000368:Aged; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D012306:Risk
D054328:Proton Pump Inhibitors; D002118:Calcium
Calcif Tissue Int. 2006 Aug;79(2):76-83
16927047
Nutr Clin Pract. 2007 Jun;22(3):286-96
17507729
Osteoporos Int. 2008 Aug;19(8):1119-23
18286218
Calcif Tissue Int. 1993 Jul;53(1):21-5
8102318
Gastroenterology. 2010 Mar;138(3):896-904
19931262
Arch Intern Med. 2010 May 10;170(9):765-71
20458083
Maturitas. 2009 Sep 20;64(1):9-13
19674854
J Clin Epidemiol. 2004 Apr;57(4):422-8
15135846
Osteoporos Int. 2009 Dec;20(12):1989-98
19333676
Artif Organs. 1998 Jul;22(7):569-73
9684693
J Clin Endocrinol Metab. 2008 Jun;93(6):2206-12
18364381
Pharmacotherapy. 2008 Aug;28(8):951-9
18657011
J Nutr. 2007 Nov;137(11 Suppl):2507S-2512S
17951494
J Bone Miner Res. 1992 May;7(5):573-9
1615763
Nephron. 2002 Jul;91(3):474-9
12119480
Calcif Tissue Int. 1998 Apr;62(4):283-5
9504949
J Am Geriatr Soc. 2007 Nov;55(11):1720-6
17916118
Nutr Rev. 1992 Feb;50(2):33-40
1570081
Bone. 2007 Apr;40(4):991-6
17182296
Gastroenterology. 2010 Jul;139(1):93-101
20353792
Aliment Pharmacol Ther. 2007 Apr 1;25(7):797-804
17373918
JAMA. 2006 Dec 27;296(24):2947-53
17190895
Lancet. 2007 Aug 25;370(9588):657-66
17720017
Am J Gastroenterol. 2009 Mar;104 Suppl 2:S2-4
19262542
Drug Saf. 2009;32(7):539-47
19530741
Calcif Tissue Int. 2009 Jan;84(1):13-9
19023510
Gerontology. 2009;55(5):496-504
19628932
N Engl J Med. 2004 May 13;350(20):2042-9
15141042
J Clin Invest. 1984 Mar;73(3):640-7
6707197
J Am Coll Nutr. 1995 Aug;14(4):364-8
8568113
Arch Intern Med. 2008 Apr 28;168(8):820-5
18443256
Am J Med. 2005 Jul;118(7):778-81
15989913
Am J Med. 2009 Jul;122(7):599-604
19559158
Nephrol Dial Transplant. 1995;10(8):1376-80
8538929
CMAJ. 2008 Aug 12;179(4):319-26
18695179